Novo Nordisk | NVO - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q2 Jun/2026 0.80 0.93 Aug/05
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31




Eps تغيير تاريخ
ANI Pharmaceuticals USD 2.05 0.28 2026-03
Aurora Cannabis CAD -0.13 0.51 2026-03
Bausch Health Companies USD 1.26 0.48 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Canopy Growth CAD -0.4 0.35 2026-03
Corcept Therapeutics USD 0.36 0.66 2026-06
Drreddys Laboratories INR 0.06 0.1 2026-03
Eli Lilly USD 8.55 1.01 2026-03
GlaxoSmithKline GBP 0.51 0.08 2026-06
Merck USD -1.28 3.32 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Novartis USD 2.41 0.42 2026-06
Novo Nordisk DKK 10.91 4.87 2026-03
Novo Nordisk DKK 1.02 0.01 2025-12
Pacira USD 0.6 0.54 2026-03
Perrigo USD 0.43 0.34 2026-03
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 1.23 0.09 2026-03
Sanofi EUR 2.09 0.21 2026-06
Supernus Pharmaceuticals USD -1.01 1.61 2026-06
Zoetis USD 1.53 0.05 2026-03